Digestive System Adenocarcinoma — Trials

Digestive System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,072 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,374
Recruiting: 799
Ph III recruiting: 82
Growth YoY: +12.1%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (619)

clinicaltrialsPublishedShowing 201–250 of 1,924 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06710132	Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)	active not recruiting	Phase 1 / Phase 2	184	EMD Serono Research & Development Institute, Inc.INDUSTRY	10	Jul 30, 2026	clinicaltrials
NCT03695250	BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer	terminated	Phase 1 / Phase 2	8	Edward KimOTHER	1	Jul 29, 2026	clinicaltrials